adbica adbica adbica (also known as adb-pica) is a designer drug identified in synthetic cannabis blends in japan in 2013. adbica had not previously been reported in the scientific literature prior to its sale as a component of synthetic cannabis blends. adbica features a carboxamide group at the 3-indole position, like sdb-001 and sts-135. the stereochemistry of the tert-butyl side-chain in the product is unresolved, though in a large series of indazole derivatives structurally similar to adbica that are disclosed in pfizer patent wo 2009/106980, activity resides exclusively in the (s) enantiomers. adbica is a potent agonist of the cb1 receptor and cb2 receptor with an ec50 value of 0.69 nm and 1.8 nm respectively. adbicaclinical dataatc coderacemate: nonelegal statuslegal status ca: schedule ii de: npsg (industrial and scientific use only) uk: class b identifiers iupac name n-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1h-indole-3-carboxamide cas numberracemate: 1445583-48-1 ypubchem cidracemate: 72710773chemspiderracemate: 29342130uniiracemate: q71g788a6hs isomer: p0248qcz04 ycomptox dashboard (epa)racemate: dtxsid801009996 chemical and physical dataformulac20h29n3o2molar mass343.471 g·mol−13d model (jsmol)racemate: interactive images isomer: interactive image smiles racemate: cccccn1c=c(c2=cc=cc=c21)c(=o)nc(c(=o)n)c(c)(c)cs isomer: cccccn1c=c(c2=cc=cc=c21)c(=o)n(c(=o)n)c(c)(c)c inchi racemate: inchi=1s/c20h29n3o2/c1-5-6-9-12-23-13-15(14-10-7-8-11-16(14)23)19(25)22-17(18(21)24)20(2,3)4/h7-8,10-11,13,17h,5-6,9,12h2,1-4h3,(h2,21,24)(h,22,25)key:ixuymxakkywkrg-uhfffaoysa-n legal status as of october 2015 adbica is a controlled substance in china.